Short-acting beta-agonist research: a perspective. 1997.


Asthma mortality increased sharply in New Zealand in 1977, prompting a national investigation into circumstances of asthma deaths. Subsequent observations of improved asthma control in subjects withdrawn from regular beta(2)-agonist treatment raised the question of whether asthma severity and, therefore, mortality could relate to frequent beta-agonist use… (More)


Cite this paper

@article{Sears2001ShortactingBR, title={Short-acting beta-agonist research: a perspective. 1997.}, author={Malcolm R Sears}, journal={Canadian respiratory journal}, year={2001}, volume={8 5}, pages={349-55} }